文献速递疝与腹壁外科急腹症与外科感染

重质与中质合成补片在清洁-污染和污染腹壁疝修补术中的短期结局:回顾性队列研究

Short-term outcomes of heavyweight versus mediumweight synthetic mesh in a retrospective cohort of clean-contaminated and contaminated retromuscular ventral hernia repairs.
PubMed 文献 · Surg Endosc · 2024-06-11

该回顾性队列研究利用美国腹壁核心健康质量协作数据库,纳入2012至2023年接受开放腹膜后腹壁疝修补术且置入中质或重质聚丙烯补片的CDC II/III类切口患者,经3:1倾向评分匹配后比较短期伤口并发症。结果显示两组在手术部位感染、手术部位事件、补片取出、再手术和30天再入院方面均无显著差异。作者结论认为重质补片未增加早期伤口并发症,但需更长期随访以确定其能否作为污染场景下中质补片的合适替代。

要点

  • 开放腹膜后腹壁疝修补术在CDC II/III类切口使用重质聚丙烯补片未增加早期伤口并发症。
  • 匹配后中质补片组与重质补片组的手术部位感染率分别为13.4%与14.5%,无显著差异。
  • 两组再手术率分别为4.6%与2.6%,30天再入院率分别为12.3%与9.4%,均无显著差异。

核心结论

  • 在开放腹膜后腹壁疝修补术治疗CDC II/III类病例中,与中质聚丙烯补片相比,重质聚丙烯补片未增加早期伤口并发症、补片取出、再手术或再入院。
  • 需要更长期随访以确定重质聚丙烯补片在污染场景下是否可作为中质聚丙烯补片的合适替代。

研究设计与样本

  • 回顾性队列研究,数据来源于美国腹壁核心健康质量协作数据库,纳入2012至2023年接受开放腹膜后腹壁疝修补术且置入中质或重质聚丙烯补片于CDC II/III类切口的患者。
  • 共1496例患者接受中质或重质聚丙烯补片(分别为1378例与118例),采用3:1倾向评分匹配分析,匹配协变量包括CDC分类、BMI、糖尿病、1年内吸烟、疝和补片宽度。
  • 匹配后中质补片组351例,重质补片组117例。

主要发现

  • 匹配后手术部位感染率中质补片组为13.4%,重质补片组为14.5%(p=0.877),无显著差异。
  • 深部手术部位感染率中质补片组为0.3%,重质补片组为0%(p=1),无显著差异。
  • 手术部位事件发生率中质补片组为17.9%,重质补片组为22.2%(p=0.377),无显著差异。
  • 需要操作干预的手术部位事件发生率中质补片组为16%,重质补片组为17.9%(p=0.719),无显著差异。
  • 补片取出率中质补片组为0.3%,重质补片组为0%(p=1);30天再手术率中质补片组为4.6%,重质补片组为2.6%(p=0.428);30天再入院率中质补片组为12.3%,重质补片组为9.4%(p=0.504),均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更长期随访以确定重质聚丙烯补片在污染场景下是否可作为中质聚丙烯补片的合适替代。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mediumweight (40-60 g/m2) polypropylene (MWPP) mesh has been shown to be safe and effective in CDC class II-III retromuscular ventral hernia repairs (RMVHR). However, MWPP has the potential to fracture, and it is possible that heavyweight (> 75 g/m2) polypropylene mesh has similar outcomes in this context. However, there is limited data on HWPP mesh performance in clean-contaminated and contaminated scenarios. We aimed to compare HWPP to MWPP mesh in CDC class II-III wounds during open RMVHR. METHODS: The Abdominal Core Health Quality Collaborative database was retrospectively queried for a cohort of patients who underwent open RMVHR with MWPP or HWPP mesh placed in CDC class II/III wounds from 2012 to 2023. Mesh types were compared using a 3:1 propensity score-matched analysis. Covariates for matching included CDC classification, BMI, diabetes, smoking within 1 year, hernia, and mesh width. Primary outcome of interest included wound complications. Secondary outcomes included reoperations and readmissions at 30 days. RESULTS: A total of 1496 patients received MWPP or HWPP (1378 vs. 118, respectively) in contaminated RMVHR. After propensity score matching, 351 patients remained in the mediumweight and 117 in the heavyweight mesh group. There were no significant differences in surgical site infection (SSI) rates (13.4% vs. 14.5%, p = 0.877), including deep SSIs (0.3% vs. 0%, p = 1), surgical site occurrence rates (17.9% vs. 22.2%, p = 0.377), surgical site occurrence requiring procedural intervention (16% vs. 17.9%, p = 0.719), mesh removal (0.3% vs. 0%, p = 1), reoperations (4.6% vs. 2.6%, p = 0.428), or readmissions (12.3% vs. 9.4%, p = 0.504) at 30 days. CONCLUSION: HWPP mesh was not associated with increased wound morbidity, mesh excisions, reoperations, or readmissions in the early postoperative period compared with MWPP mesh in open RMVHR for CDC II/III cases. Longer follow-up will be necessary to determine if HWPP mesh may be a suitable alternative to MWPP mesh in contaminated scenarios.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ellis RC, Maskal SM, Messer N, et al. Short-term outcomes of heavyweight versus mediumweight synthetic mesh in a retrospective cohort of clean-contaminated and contaminated retromuscular ventral hernia repairs. Surg Endosc. 2024. PMID: 38862822. doi:10.1007/s00464-024-10946-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。